The incorporation of multiple metal atoms in multivariate
metal–organic
frameworks is typically carried out through a one-pot synthesis procedure
that involves the simultaneous reaction of the selected elements with
the organic linkers. In order to attain control over the distribution
of the elements and to be able to produce materials with controllable
metal combinations, it is required to understand the synthetic and
crystallization processes. In this work, we have completed a study
with the RPF-4 MOF family, which is made of various rare-earth elements,
to investigate and determine how the different initial combinations
of metal cations result in different atomic distributions in the obtained
materials. Thus, we have found that for equimolar combinations involving
lanthanum and another rare-earth element, such as ytterbium, gadolinium,
or dysprosium, a compositional segregation takes place in the products,
resulting in crystals with different compositions. On the contrary,
binary combinations of ytterbium, gadolinium, erbium, and dysprosium
result in homogeneous distributions. This dissimilar behavior is ascribed
to differences in the crystallization pathways through which the MOF
is formed. Along with the synthetic and crystallization study and
considering the structural features of this MOF family, we also disclose
here a comprehensive characterization of the magnetic properties of
the compounds and the heat capacity behavior under different external
magnetic fields.
Two novel bicomponent solid forms of mebendazole (MBZ), were developed as a mean to modulate its psychochemical and pharmaceutical properties. Supramolecular synthesis of MBZ A or C with perchloric or...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.